Original language | English (US) |
---|---|
Pages (from-to) | 699-703.e7 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 139 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2017 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. / Tan, Bruce K.; Klingler, Aiko I.; Poposki, Julie A. et al.
In: Journal of Allergy and Clinical Immunology, Vol. 139, No. 2, 01.02.2017, p. 699-703.e7.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois
AU - Tan, Bruce K.
AU - Klingler, Aiko I.
AU - Poposki, Julie A.
AU - Stevens, Whitney W.
AU - Peters, Anju T.
AU - Suh, Lydia A.
AU - Norton, James
AU - Carter, Roderick G.
AU - Hulse, Kathryn E.
AU - Harris, Kathleen E.
AU - Grammer, Leslie C.
AU - Schleimer, Robert P.
AU - Welch, Kevin C.
AU - Smith, Stephanie S.
AU - Conley, David B.
AU - Kern, Robert C.
AU - Kato, Atsushi
N1 - Funding Information: Disclosure of potential conflict of interest: B. K. Tan has received grants from the National Institutes of Health (grant nos. K23 DC012067 and U19 AI106683). A. T. Peters has consultant arrangements with Greer Laboratories. K. E. Hulse has received a grant from the National Institutes of Health. K. E. Harris is employed by Northwestern University. L. C. Grammer has received grants from the National Institutes of Health, the Food Allergy Network, and the Bazley Foundation; has consultant arrangements with Astellas Pharmaceuticals; is employed by Northwestern University and Northwestern Medical Faculty Foundation; has received payment for lectures from the American Academy of Allergy, Asthma, and Immunology and Mount Sinai; has received royalties from Lippincott, UpToDate, BMJ, and Elsevier; and has received travel support from the National Institutes of Health. R. P. Schleimer has received grants from the National Institutes of Health; has consultant arrangements with Intersect ENT, GlaxoSmithKline, Allakos, Aurasense, Merck, BioMarck, Sanofi, AstraZeneca/MedImmune, and Genentech; and has stock/stock options in Allakos, Aurasense, and BioMarck. S. S. Smith has received a grant from the Triological Society Career Development Award and is employed by Northwestern Medicine/Northwestern University. A. Kato has received grants from the National Institutes of Health (grant nos. R01 AI104733 and U19 AI106683) and Janssen Research and has received payment for lectures from Janssen Research. The rest of the authors declare that they have no relevant conflicts of interest. Letter to the Editor Funding Information: This research was supported in part by the National Institutes of Health (grant nos. R01 AI104733 , U19 AI106683 , K23 DC012067 , and R37 HL068546 ) and by a grant from the Ernest S. Bazley Foundation .
PY - 2017/2/1
Y1 - 2017/2/1
UR - http://www.scopus.com/inward/record.url?scp=85002145866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85002145866&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2016.06.063
DO - 10.1016/j.jaci.2016.06.063
M3 - Article
C2 - 27639939
AN - SCOPUS:85002145866
VL - 139
SP - 699-703.e7
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 2
ER -